T1-mapping in the heart: accuracy and precision
Peter Kellman, Michael S Hansen, Peter Kellman, Michael S Hansen
Abstract
The longitudinal relaxation time constant (T1) of the myocardium is altered in various disease states due to increased water content or other changes to the local molecular environment. Changes in both native T1 and T1 following administration of gadolinium (Gd) based contrast agents are considered important biomarkers and multiple methods have been suggested for quantifying myocardial T1 in vivo. Characterization of the native T1 of myocardial tissue may be used to detect and assess various cardiomyopathies while measurement of T1 with extracellular Gd based contrast agents provides additional information about the extracellular volume (ECV) fraction. The latter is particularly valuable for more diffuse diseases that are more challenging to detect using conventional late gadolinium enhancement (LGE). Both T1 and ECV measures have been shown to have important prognostic significance. T1-mapping has the potential to detect and quantify diffuse fibrosis at an early stage provided that the measurements have adequate reproducibility. Inversion recovery methods such as MOLLI have excellent precision and are highly reproducible when using tightly controlled protocols. The MOLLI method is widely available and is relatively mature. The accuracy of inversion recovery techniques is affected significantly by magnetization transfer (MT). Despite this, the estimate of apparent T1 using inversion recovery is a sensitive measure, which has been demonstrated to be a useful tool in characterizing tissue and discriminating disease. Saturation recovery methods have the potential to provide a more accurate measurement of T1 that is less sensitive to MT as well as other factors. Saturation recovery techniques are, however, noisier and somewhat more artifact prone and have not demonstrated the same level of reproducibility at this point in time.This review article focuses on the technical aspects of key T1-mapping methods and imaging protocols and describes their limitations including the factors that influence their accuracy, precision, and reproducibility.
Figures
References
- Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92. doi: 10.1186/1532-429X-15-92.
- Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126(10):1206–16. doi: 10.1161/CIRCULATIONAHA.111.089409.
- Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2013. doi: 10.1093/eurheartj/eht193.
- Pennell DJ, Sechtem UP, Higgins CB. et al.Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004;25:1940–65. doi: 10.1016/j.ehj.2004.06.040.
- Hunold P, Schlosser T, Vogt FM. et al.Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Am J Roentgenol. 2005;184(5):1420–6. doi: 10.2214/ajr.184.5.01841420.
- Sado DM, Flett AS, Moon JC. Novel imaging techniques for diffuse myocardial fibrosis. Future Cardiol. 2011;7(5):643–50. doi: 10.2217/fca.11.45.
- Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57(8):891–903. doi: 10.1016/j.jacc.2010.11.013.
- Gai N, Turkbey EB, Nazarian S. et al.T1 mapping of the gadolinium- enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med. 2011;65(5):1407–15. doi: 10.1002/mrm.22716.
- Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson. 2011;13(1):75. doi: 10.1186/1532-429X-13-75.
- Arheden H, Saeed M, Higgins CB. et al.Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar mr imaging to quantify myocardial infarction: comparison with 99mtc-dtpa autoradiography in rats. Radiology. 1999;211:698–708. doi: 10.1148/radiology.211.3.r99jn41698.
- Jerosch-Herold M, Sheridan DC, Kushner JD. et al.Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008;295:H1234–42. doi: 10.1152/ajpheart.00429.2008.
- Flett AS, Hayward MP, Ashworth MT. et al.Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122(2):138–44. doi: 10.1161/CIRCULATIONAHA.109.930636.
- Kehr E, Sono M, Chugh S, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24:61–8.
- Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727–34. doi: 10.1161/CIRCIMAGING.108.842096.
- Schelbert E, Testa SM, Meier CG. et al.Myocardial extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson. 2011;13:16. doi: 10.1186/1532-429X-13-16.
- Ugander M, Oki AJ, Hsu L-Y. et al.Extracellular volume imaging by MRI provides insight into overt and subclinical myocardial pathology. Eur Heart J. 2012;33(10):1268–78. doi: 10.1093/eurheartj/ehr481.
- Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64. doi: 10.1186/1532-429X-14-64.
- Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475–84. doi: 10.1016/j.jcmg.2012.08.019.
- Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2003;5:353–9. doi: 10.1081/JCMR-120019418.
- Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med. 2007;58:34–40. doi: 10.1002/mrm.21272.
- Ugander M, Bagi PS, Oki AJ. et al.Myocardial edema as detected by pre-contrast T1 and T2 MRI delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5(6):596–603. doi: 10.1016/j.jcmg.2012.01.016.
- Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:42. doi: 10.1186/1532-429X-14-42.
- Dall’Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson. 2012;14:15. doi: 10.1186/1532-429X-14-15.
- Ferreira VM, Piechnik SK, Dall’armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013. doi:10.1016/j.jcmg.2013.03.008 [Epub ahead of print]
- Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488–97. doi: 10.1016/j.jcmg.2012.11.013.
- Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6:295–301. doi: 10.1161/CIRCIMAGING.112.000151.
- Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC. The identification and assessment of Anderson Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392–8.
- Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE, Hansen ES, Kim WY. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson. 2012;14:59. doi: 10.1186/1532-429X-14-59.
- Feng Y, He T, Carpenter J-P, Jabbour A, Alam MH, Gatehouse PD, Greiser A, Messroghli D, Firmin DN, Pennell DJ. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013;38:588–93. doi: 10.1002/jmri.24010.
- Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574–80. doi: 10.1016/j.jacc.2008.06.049.
- Flacke SJ, Fischer SE, Lorenz CH. Cardiac imaging abbreviations: gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001;218:703–710. doi: 10.1148/radiology.218.3.r01fe18703.
- Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52:141–6. doi: 10.1002/mrm.20110.
- Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69. doi: 10.1186/1532-429X-12-69.
- Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012;14:63. doi: 10.1186/1532-429X-14-63.
- Xue H, Shah S, Greiser A. et al.Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67(6):1644–55. doi: 10.1002/mrm.23153.
- Xue H, Greiser A, Zuehlsdorff S, Jolly MP, Guehring J, Arai AE, Kellman P. Phase-sensitive inversion recovery for myocardial T(1) mapping with motion correction and parametric fitting. Magn Reson Med. 2013;69(5):1408–20. doi: 10.1002/mrm.24385.
- Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look- locker inversion-recovery (MOLLI) T1mapping of the heart. J Magn Reson Imaging. 2007;26:1081–6. doi: 10.1002/jmri.21119.
- Gai ND, Stehning C, Nacif M, Bluemke D. Modified Look-Locker T(1) evaluation using Bloch simulations: human and phantom validation. Magn Reson Med. 2013;69(2):329–336. doi: 10.1002/mrm.24251.
- Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH. Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T(1) mapping. J Magn Reson Imaging. 2013;38(1):217–224. doi: 10.1002/jmri.23875.
- Kellman P, Herzka DA, Hansen MS. Adiabatic inversion pulses for myocardial T1-mapping. Magn Res Med. 2013. doi:10.1002/mrm.24793. [Epub ahead of print]
- Kellman P, Arai AE, Xue H. T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson. 2013;15:56. doi: 10.1186/1532-429X-15-56.
- Kellman P, Herzka DA, Arai AE, Hansen MS. Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI method. J Cardiovasc Magn Reson. 2013;15:63. doi: 10.1186/1532-429X-15-63.
- Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA. T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys. 2005;32:1738. doi: 10.1118/1.1921668.
- Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med. 2013. doi: 10.1002/mrm.24878. [Epub ahead of print]
- Weingärtner S, Akçakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med. 2013. doi: 10.1002/mrm.24761. [Epub ahead of print]
- Deichmann R, Haase A. Quantification of Tl Values by SNAPSHOT-FLASH NMR Imaging. J Magn Reson. 1992;612:608–12.
- Schmitt P, Griswold MA, Jakob PM, Kotas M, Gulani V, Flentje M, Haase A. Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Magn Reson Med. 2004;51:661–667. doi: 10.1002/mrm.20058.
- Song T, Stainsby JA, Ho VB, Hood MN, Slavin GS. Flexible cardiac T1 mapping using a modified Look-Locker acquisition with saturation recovery. Magn Reson Med. 2012;67:622–627. doi: 10.1002/mrm.24137.
- Sung K, Nayak KS. Design and use of tailored hard-pulse trains for uniformed saturation of myocardium at 3 Tesla. Magn Reson Med. 2008;60:997–1002. doi: 10.1002/mrm.21765.
- Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13. doi: 10.1186/1532-429X-15-13.
- Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med. 2013;670:664–70.
- Dousset V, Degreze P, Mieze S, Sessay M, Basse-Cathalinat B, Caille J-M. Magnetization transfer on in vitro circulating blood: implications for time-of-flight angiography. JMRI. 1995;5:786–8. doi: 10.1002/jmri.1880050630.
- Hernandez-Garcia L, Lewis DP, Moffat B, Branch CA. Magnetization transfer effects on the efficiency of flow-driven adiabatic fast passage inversion of arterial blood. NMR Biomed. 2007;20:733–42. doi: 10.1002/nbm.1137.
- Pike GB, Hu BS, Glover GH, Enzmann DR. Magnetization transfer time-of-flight magnetic resonance angiography. Magn Reson Med. 1992;25:372–9. doi: 10.1002/mrm.1910250217.
- Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJM, Schmitt M. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373–83.
- Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012;14:26. doi: 10.1186/1532-429X-14-26.
Source: PubMed